BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1684071)

  • 1. Effects of polychlorinated biphenyls in rat liver: quantitative analysis of enzyme-altered foci.
    Luebeck EG; Moolgavkar SH; Buchmann A; Schwarz M
    Toxicol Appl Pharmacol; 1991 Dec; 111(3):469-84. PubMed ID: 1684071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of polychlorinated biphenyls in rat liver: correlation between primary subcellular effects and promoting activity.
    Buchmann A; Ziegler S; Wolf A; Robertson LW; Durham SK; Schwarz M
    Toxicol Appl Pharmacol; 1991 Dec; 111(3):454-68. PubMed ID: 1684070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of multiple phenotype enzyme-altered foci in rat hepatocarcinogenesis experiments: the multipath/multistage model.
    Sherman CD; Portier CJ
    Carcinogenesis; 1995 Oct; 16(10):2499-506. PubMed ID: 7586158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing effect of co-administration of polychlorinated biphenyls and diethylnitrosamine on enzyme-altered islands induced by diethylnitrosamine in rat liver.
    Deml E; Oesterle D
    Carcinogenesis; 1986 Oct; 7(10):1697-700. PubMed ID: 2875810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three rat liver foci bioassays--incidence of preneoplastic foci initiated by diethylnitrosamine.
    Oesterle D; Gerbracht U; Deml E; Schlatterer B; Eigenbrodt E
    Carcinogenesis; 1989 Oct; 10(10):1891-5. PubMed ID: 2571425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
    LeBoeuf RA; Laishes BA; Hoekstra WG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polychlorinated biphenyls, classified as either phenobarbital- or 3-methylcholanthrene-type inducers of cytochrome P-450, are both hepatic tumor promoters in diethylnitrosamine-initiated rats.
    Buchmann A; Kunz W; Wolf CR; Oesch F; Robertson LW
    Cancer Lett; 1986 Sep; 32(3):243-53. PubMed ID: 3094931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital.
    Goldsworthy TL; Pitot HC
    Carcinogenesis; 1985 Sep; 6(9):1261-9. PubMed ID: 2863007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2',5'-tetrachlorobiphenyl, and/or 3,4,3'4'-tetrachlorobiphenyl in rat liver.
    Sargent LM; Sattler GL; Roloff B; Xu YH; Sattler CA; Meisner L; Pitot HC
    Cancer Res; 1992 Feb; 52(4):955-62. PubMed ID: 1737357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary retinyl palmitate on the promotion of altered hepatic foci by 3,3',4,4'-tetrachlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl in rats initiated with diethylnitrosamine.
    Berberian I; Chen LC; Robinson FR; Glauert HP; Chow CK; Robertson LW
    Carcinogenesis; 1995 Feb; 16(2):393-8. PubMed ID: 7859372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin.
    Moolgavkar SH; Luebeck EG; Buchmann A; Bock KW
    Toxicol Appl Pharmacol; 1996 May; 138(1):31-42. PubMed ID: 8658510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The initiation-promotion-progression model of rat hepatocarcinogenesis.
    Dragan YP; Sargent L; Xu YD; Xu YH; Pitot HC
    Proc Soc Exp Biol Med; 1993 Jan; 202(1):16-24. PubMed ID: 8093813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine.
    Williams GM; Gebhardt R; Sirma H; Stenbäck F
    Carcinogenesis; 1993 Oct; 14(10):2149-56. PubMed ID: 8106178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response of promotion by polychlorinated biphenyls and chloroform in rat liver foci bioassay.
    Deml E; Oesterle D
    Arch Toxicol; 1987; 60(1-3):209-11. PubMed ID: 2887150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
    Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
    Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats.
    Dragan YP; Campbell HA; Xu XH; Pitot HC
    Carcinogenesis; 1997 Jan; 18(1):149-58. PubMed ID: 9054601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC; Popp JA
    Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbance of the cell cycle with colchicine enhances the growth advantage of diethylnitrosamine-initiated hepatocytes in rats.
    Tsutsumi M; Ohashi K; Tsujiuchi T; Kobayashi E; Kobitsu K; Kitada H; Majima T; Okajima E; Endoh T; Hasegawa K; Mori T; Konishi Y
    Jpn J Cancer Res; 1996 Jan; 87(1):5-9. PubMed ID: 8609048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration.
    Goldsworthy T; Campbell HA; Pitot HC
    Carcinogenesis; 1984 Jan; 5(1):67-71. PubMed ID: 6140089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital.
    Bishayee A; Chatterjee M
    Br J Cancer; 1995 Jun; 71(6):1214-20. PubMed ID: 7779714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.